Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine combinations for electroconvulsive therapy anesthesia
IRCT20160307026950N23Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ketamine, midazolam and dexmedetomidine in conditions requiring electroconvulsive therapy (2 arms), sponsored by Isfahan University of Medical Sciences. Started Sep 2020; status: completed.
02
Drugs
ketaminemidazolamdexmedetomidine
03
Conditions
conditions requiring electroconvulsive therapy
Beyond the preview
Go deeper on IRCT20160307026950N23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N23.